Total Clarity Wealth Management, Inc. Novo Nordisk A S Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$103.24 - $121.81 $21,060 - $24,849	204 New	204 $23,000
Q1 2022 Apr 29, 2022	SELL	$93.1 - $112.54 $18,992 - $22,958	-204 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$95.88 - $117.08 $4,314 - $5,268	45 Added 28.3%	204 $23,000
Q3 2021 Oct 21, 2021	BUY	$84.42 - $106.62 $13,422 - $16,952	159 New	159 $15,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.